Clinical trials
Recruiting Phase 2 beta-Thalassemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Mitchell Cairo | 1 |
| National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | 1 |
| Paul Szabolcs | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| beta-Thalassemia | 6 |
| Anemia, Sickle Cell | 3 |
| Anemia, Diamond-Blackfan | 2 |
| Thalassemia | 2 |
| Adrenoleukodystrophy | 1 |
| Anemia, Aplastic | 1 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Arthritis, Juvenile | 1 |
| Autoimmune Lymphoproliferative Syndrome | 1 |
| Chediak-Higashi Syndrome | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.